A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.
Saved in:
| Title: | A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis. |
|---|---|
| Authors: | Liu, Yaxin1 (AUTHOR), Wang, Wei2 (AUTHOR), Yin, Rutie3 (AUTHOR), Zhang, Youzhong4 (AUTHOR), Zhang, Yu5 (AUTHOR), Zhang, Keqiang6 (AUTHOR), Pan, Hongming7 (AUTHOR), Wang, Ke8 (AUTHOR), Lou, Ge9 (AUTHOR), Li, Guiling10 (AUTHOR), Zhang, Ruyan1 (AUTHOR), Li, Kun1 (AUTHOR), Rao, Jing11 (AUTHOR), Zhang, Ben11 (AUTHOR), Wang, Yuting11 (AUTHOR), Wang, Quanren11 (AUTHOR), Gao, Yunong2 (AUTHOR) gao_fuke@126.com, Li, Huiping1 (AUTHOR) huipingli2012@hotmail.com |
| Source: | BMC Medicine. 9/29/2023, Vol. 21 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 172439922 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Liu%2C+Yaxin%22">Liu, Yaxin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Wei%22">Wang, Wei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yin%2C+Rutie%22">Yin, Rutie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Youzhong%22">Zhang, Youzhong</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yu%22">Zhang, Yu</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Keqiang%22">Zhang, Keqiang</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Hongming%22">Pan, Hongming</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Ke%22">Wang, Ke</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lou%2C+Ge%22">Lou, Ge</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Guiling%22">Li, Guiling</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Ruyan%22">Zhang, Ruyan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Kun%22">Li, Kun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rao%2C+Jing%22">Rao, Jing</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Ben%22">Zhang, Ben</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yuting%22">Wang, Yuting</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Quanren%22">Wang, Quanren</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+Yunong%22">Gao, Yunong</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> gao_fuke@126.com</i><br /><searchLink fieldCode="AR" term="%22Li%2C+Huiping%22">Li, Huiping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> huipingli2012@hotmail.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 9/29/2023, Vol. 21 Issue 1, p1-10. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=172439922 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12916-023-03046-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Titles: – TitleFull: A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu, Yaxin – PersonEntity: Name: NameFull: Wang, Wei – PersonEntity: Name: NameFull: Yin, Rutie – PersonEntity: Name: NameFull: Zhang, Youzhong – PersonEntity: Name: NameFull: Zhang, Yu – PersonEntity: Name: NameFull: Zhang, Keqiang – PersonEntity: Name: NameFull: Pan, Hongming – PersonEntity: Name: NameFull: Wang, Ke – PersonEntity: Name: NameFull: Lou, Ge – PersonEntity: Name: NameFull: Li, Guiling – PersonEntity: Name: NameFull: Zhang, Ruyan – PersonEntity: Name: NameFull: Li, Kun – PersonEntity: Name: NameFull: Rao, Jing – PersonEntity: Name: NameFull: Zhang, Ben – PersonEntity: Name: NameFull: Wang, Yuting – PersonEntity: Name: NameFull: Wang, Quanren – PersonEntity: Name: NameFull: Gao, Yunong – PersonEntity: Name: NameFull: Li, Huiping IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 09 Text: 9/29/2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 17417015 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: BMC Medicine Type: main |
| ResultId | 1 |